Saturday 17 October 2026
Export TEVA’s income statement to Excel — free account
Teva Pharmaceutical Industries Ltd.
TEVA Healthcare Drug Manufacturers Specialty & Generic
In the quarter to June 2026, revenue was flat, EPS fell 296.0%, free cash flow grew 121.4% and total debt fell 3.69%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
41.52
0.41
+1.00%
Follow TEVA
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
3,556.00 | 3,300.00 | 3,226.00 | 2,801.00 | 2,165.00 | 2,177.00 | 1,975.00 | 1,782.00 | 963.00 | 988.00 |
Receivables |
3,709.00 | 3,059.00 | 3,408.00 | 3,696.00 | 4,529.00 | 4,581.00 | 5,676.00 | 5,822.00 | 7,128.00 | 7,523.00 |
Inventory |
3,179.00 | 3,007.00 | 4,021.00 | 3,833.00 | 3,818.00 | 4,403.00 | 4,422.00 | 4,731.00 | 4,924.00 | 4,954.00 |
Other current assets |
539.00 | 409.00 | 504.00 | 549.00 | 965.00 | 710.00 | 434.00 | 468.00 | 701.00 | 1,293.00 |
Total current assets |
13,946.00 | 12,552.00 | 12,485.00 | 12,051.00 | 12,573.00 | 13,005.00 | 13,464.00 | 13,794.00 | 15,382.00 | 17,228.00 |
Property, Plant, Equpment (Net) |
4,080.00 | 4,581.00 | 5,750.00 | 5,739.00 | 5,982.00 | 6,296.00 | 6,436.00 | 6,868.00 | 7,673.00 | 8,073.00 |
Goodwill and Intangible Assets (Total) |
19,781.00 | 19,565.00 | 22,564.00 | 23,903.00 | 27,506.00 | 29,547.00 | 36,078.00 | 38,922.00 | 46,054.00 | 65,896.00 |
Long Term Assets (Tax, Deferred) |
2,191.00 | 1,799.00 | 1,812.00 | 1,458.00 | 596.00 | 695.00 | 386.00 | 368.00 | 574.00 | 625.00 |
Long-term assets (Other) |
405.00 | 462.00 | 470.00 | 441.00 | 515.00 | 538.00 | 591.00 | 731.00 | 932.00 | 1,235.00 |
Total non-current assets |
26,802.00 | 26,774.00 | 30,993.00 | 31,960.00 | 35,094.00 | 37,635.00 | 44,005.00 | 46,889.00 | 55,233.00 | 75,829.00 |
Total Assets |
40,748.00 | 39,326.00 | 43,479.00 | 44,011.00 | 47,666.00 | 50,640.00 | 57,470.00 | 60,683.00 | 70,615.00 | 93,057.00 |
Accounts Payable |
2,531.00 | 2,203.00 | 2,602.00 | 1,887.00 | 1,686.00 | 1,756.00 | 1,718.00 | 1,853.00 | 2,069.00 | 2,157.00 |
Accrued Expenses |
3,426.00 | 3,416.00 | 3,382.00 | 2,717.00 | 2,771.00 | 2,465.00 | 2,562.00 | 2,738.00 | 3,563.00 | 4,264.00 |
Current Part of Debt |
1,820.00 | 1,781.00 | 1,672.00 | 2,109.00 | 1,426.00 | 3,188.00 | 2,345.00 | 2,216.00 | 3,646.00 | 3,276.00 |
Other current liabilities |
5,325.00 | 4,698.00 | 4,579.00 | 4,755.00 | 5,144.00 | 5,757.00 | 7,048.00 | 7,515.00 | 8,605.00 | 8,675.00 |
Total current liabilities |
13,456.00 | 12,796.00 | 12,247.00 | 11,469.00 | 11,027.00 | 13,164.00 | 13,674.00 | 14,322.00 | 17,921.00 | 18,488.00 |
Long Term Debt (Total) |
14,986.00 | 16,002.00 | 18,161.00 | 19,103.00 | 21,617.00 | 22,731.00 | 24,562.00 | 26,700.00 | 28,829.00 | 32,524.00 |
Long Term Tax Liability (Deferred) |
296.00 | 483.00 | 606.00 | 548.00 | 784.00 | 964.00 | 1,096.00 | 2,140.00 | 3,277.00 | 5,413.00 |
Minority Interests |
— | 340.00 | — | — | — | — | — | — | — | — |
Non-current Liabilities (Other) |
3,808.00 | 4,028.00 | 4,019.00 | 3,945.00 | 2,578.00 | 2,240.00 | 2,640.00 | 1,727.00 | 1,843.00 | 1,639.00 |
Total non-current liabilities |
19,378.00 | 21,149.00 | 23,106.00 | 23,945.00 | 25,395.00 | 26,414.00 | 28,733.00 | 30,567.00 | 33,949.00 | 39,576.00 |
Total liabilities |
32,834.00 | 33,946.00 | 35,353.00 | 35,413.00 | 36,422.00 | 39,579.00 | 42,407.00 | 44,889.00 | 51,870.00 | 58,064.00 |
Additional Paid In Capital |
28,133.00 | 27,764.00 | 27,807.00 | 27,688.00 | 27,561.00 | 27,443.00 | 27,312.00 | 27,210.00 | 23,479.00 | 23,409.00 |
Preferred Stock (Total) |
— | — | — | — | — | — | — | — | 3,631.00 | 3,620.00 |
Common Stock (Net) |
58.00 | 58.00 | 57.00 | 57.00 | 57.00 | 57.00 | 56.00 | 56.00 | 54.00 | 54.00 |
Retained Earnings |
(13,762.00) | (15,173.00) | (13,534.00) | (12,975.00) | (10,529.00) | (10,946.00) | (6,956.00) | (5,958.00) | (3,803.00) | 13,607.00 |
Treasury Stock |
4,128.00 | 4,128.00 | 4,128.00 | 4,128.00 | 4,128.00 | 4,128.00 | 4,128.00 | 4,142.00 | 4,149.00 | 4,194.00 |
Common Equity (Total) |
7,914.00 | 5,380.00 | 8,125.00 | 8,598.00 | 11,244.00 | 11,062.00 | 15,063.00 | 15,794.00 | 15,114.00 | 31,373.00 |
Shareholders Equity (Total) |
7,914.00 | 5,380.00 | 8,126.00 | 8,598.00 | 11,244.00 | 11,061.00 | 15,063.00 | 15,794.00 | 18,745.00 | 34,993.00 |
Shareholders Equity and Liabilities (Total) |
40,748.00 | 39,326.00 | 43,479.00 | 44,011.00 | 47,666.00 | 50,640.00 | 57,470.00 | 60,683.00 | 70,615.00 | 93,057.00 |
Shares (Common) |
1,150.00 | 1,133.00 | 1,121.00 | 1,111.00 | 1,103.00 | 1,096.00 | 1,092.00 | 1,090.00 | 1,017.00 | 1,015.00 |
Shareholders Equity (Tangible) |
(11,867.00) | (14,185.00) | (14,438.00) | (15,305.00) | (16,262.00) | (18,486.00) | (21,015.00) | (23,128.00) | (27,309.00) | (30,903.00) |
Net Debt |
13,250.00 | 14,483.00 | 16,607.00 | 18,411.00 | 20,878.00 | 23,742.00 | 24,932.00 | 27,134.00 | 31,512.00 | 34,812.00 |
Total Debt |
16,806.00 | 17,783.00 | 19,833.00 | 21,212.00 | 23,043.00 | 25,919.00 | 26,907.00 | 28,916.00 | 32,475.00 | 35,800.00 |
In millions of $ except per-share values · columns are period end dates